UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME
Sales, net	$ 11,340	$ 12,520
Cost of goods sold	4,574	4,677
Gross profit	6,766	7,843
Operating expense
Selling, general and administrative	2,617	3,260
Research & development	266	144
Total operating expenses	2,883	3,404
Operating income	3,883	4,439
Other income	915	680
Income before provision for income taxes	4,798	5,119
Provision for income taxes	842	905
Net income	$ 3,956	$ 4,214
Earnings per common share (basic)	$ 1.09	$ 1.16
Earnings per common share (diluted)	$ 1.09	$ 1.16
Shares outstanding (basic)	3,618	3,628
Shares outstanding (diluted)	3,618	3,636
Other comprehensive income (loss)
Foreign currency translation net of taxes of $0 in all periods	$ (631)	$ 549
Total comprehensive income	$ 3,325	$ 4,763